Triple
T16750409
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | SmithKline Beckman |
E407057
|
entity |
| Predicate | successorInPharmaceuticalBusiness |
P124494
|
FINISHED |
| Object | GlaxoSmithKline |
E2086
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: GlaxoSmithKline | Statement: [SmithKline Beckman, successorInPharmaceuticalBusiness, GlaxoSmithKline]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: GlaxoSmithKline Context triple: [SmithKline Beckman, successorInPharmaceuticalBusiness, GlaxoSmithKline]
-
A.
GlaxoSmithKline
chosen
GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
-
B.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
C.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
D.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
E.
Burroughs Wellcome Company
Burroughs Wellcome Company was a pioneering American pharmaceutical firm known for its significant contributions to drug research and development in the 20th century.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: successorInPharmaceuticalBusiness Context triple: [SmithKline Beckman, successorInPharmaceuticalBusiness, GlaxoSmithKline]
-
A.
successorInMarket
Indicates that one entity has taken over or followed another in serving the same market or customer base.
-
B.
successorIndustryName
Indicates the name of the industry that succeeds or replaces a previous industry in a sequence or transition.
-
C.
successorInPractice
Indicates that one entity has taken over the role, position, or function of another in actual practice, even if not formally or officially designated as its successor.
-
D.
successorManufacturer
Indicates that one manufacturer has taken over, replaced, or continued the role or operations of another manufacturer as its successor.
-
E.
successor
Indicates that one entity directly follows another in an ordered sequence or position.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8838ffb088190a0b11149929006bf |
completed | April 10, 2026, 4:58 a.m. |
| NER | Named-entity recognition | batch_69e3aa265a908190a87fa4612bfe6396 |
completed | April 18, 2026, 3:58 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a00d44d0a6c819099d9bbef51001846 |
completed | May 10, 2026, 6:54 p.m. |
| PD | Predicate disambiguation | batch_69e319cbd79c8190a03587a61c18bec0 |
completed | April 18, 2026, 5:42 a.m. |
| PDg | Predicate description generation | batch_69e326b9e84881909a9166e65bd850d6 |
completed | April 18, 2026, 6:37 a.m. |
Created at: April 10, 2026, 5:21 a.m.